규제 업데이트

The Korean MFDS has ordered a retailer‑initiated recall of Il Dong Pharmaceutical’s Consenvita Premium 800 tablets (batch RWC009, RWC010) because of missing labeling information and packaging errors.

A pharmacist reports an unexpectedly severe tax audit assessment and receives advice on the taxpayer’s right to appeal and the pre‑notice review stage.

Amgen voluntarily recalls about 1 million bottles of its heart‑failure drug Corlanor in the US after potential foreign particles were identified.

Supporters of Korea's health‑insurance co‑payment cap grew by an average 6.5% per year, reaching 2.135 million in 2025 with expenditures of 2.792 trillion KRW.

Analysis shows 139 of 226 Korean local governments failed to meet mandatory disability employment rates for 2025.

Lawmaker Choi Hyuk‑jin introduced a bill to amend the Content Industry Promotion Act, aiming to ensure equal access and participation for disabled, elderly, and multicultural families.

32 drugs were newly listed or had expanded coverage, benefiting about 76,600 patients and costing roughly 741 billion KRW annually.

The Korean Pharmaceutical Association urges amendment of the Veterinarian Act to require veterinarians and animal hospitals to report usage of human prescription drugs, citing limits of the current pharmacy sales reporting system.

경방신약이 제조관리기준서 등 지시서 미준수로 식품의약품안전처로부터 7월 한 달간 두 품목 제조 정지 처분을 받았다.

New bills aim to tighten OTC drug sales to minors and require pharmacies to keep sales records, sparking debate over added burdens on pharmacies.

The 12th full meeting of the Minimum Wage Committee will resume on the 7th to discuss the 2027 wage, with pharmacies closely watching the outcome for staffing cost planning.

The Korean Pharmaceutical Association continued its 292‑day relay protest, urging the government to resolve the herbal pharmacist’s right to open pharmacies and sell OTC medicines.